Testing effectiveness (Phase 2)Study completedNCT01663116
What this trial is testing
Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients
Who this might be right for
Rheumatoid Arthritis Aggravated
Tigenix S.A.U. 53